[1]
2025. Improvement of Suspected Linear Morphea seen with Topical Ruxolitinib. SKIN The Journal of Cutaneous Medicine. 9, 1 (Jan. 2025), 2130–2133. DOI:https://doi.org/10.25251/skin.9.1.16.